These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Synthesis and biological activity of novel alpha-conotoxin analogues incorporating substituted proline derivatives. Armishaw CJ; Jensen AA; Skonberg C; Liljefors T; Strømgaard K Adv Exp Med Biol; 2009; 611():179-80. PubMed ID: 19400149 [No Abstract] [Full Text] [Related]
6. The synthesis of SO-3, a conopeptide with high analgesic activity derived from Conus striatus. Dai Q; Liu F; Zhou Y; Lu B; Yu F; Huang P J Nat Prod; 2003 Sep; 66(9):1276-9. PubMed ID: 14510617 [TBL] [Abstract][Full Text] [Related]
7. Conotoxins that confer therapeutic possibilities. Essack M; Bajic VB; Archer JAC Mar Drugs; 2012 Jun; 10(6):1244-1265. PubMed ID: 22822370 [TBL] [Abstract][Full Text] [Related]
8. Sodium channel modulating activity in a delta-conotoxin from an Indian marine snail. Sudarslal S; Majumdar S; Ramasamy P; Dhawan R; Pal PP; Ramaswami M; Lala AK; Sikdar SK; Sarma SP; Krishnan KS; Balaram P FEBS Lett; 2003 Oct; 553(1-2):209-12. PubMed ID: 14550575 [TBL] [Abstract][Full Text] [Related]
9. A synthetic combinatorial strategy for developing alpha-conotoxin analogs as potent alpha7 nicotinic acetylcholine receptor antagonists. Armishaw CJ; Singh N; Medina-Franco JL; Clark RJ; Scott KC; Houghten RA; Jensen AA J Biol Chem; 2010 Jan; 285(3):1809-21. PubMed ID: 19901032 [TBL] [Abstract][Full Text] [Related]
10. Discovery Methodology of Novel Conotoxins from Fu Y; Li C; Dong S; Wu Y; Zhangsun D; Luo S Mar Drugs; 2018 Oct; 16(11):. PubMed ID: 30380764 [TBL] [Abstract][Full Text] [Related]
11. Neuroprotective and cardioprotective conopeptides: an emerging class of drug leads. Twede VD; Miljanich G; Olivera BM; Bulaj G Curr Opin Drug Discov Devel; 2009 Mar; 12(2):231-9. PubMed ID: 19333868 [TBL] [Abstract][Full Text] [Related]
12. Conotoxins as research tools and drug leads. Armishaw CJ; Alewood PF Curr Protein Pept Sci; 2005 Jun; 6(3):221-40. PubMed ID: 15974949 [TBL] [Abstract][Full Text] [Related]
15. Molecular engineering of conotoxins: the importance of loop size to alpha-conotoxin structure and function. Jin AH; Daly NL; Nevin ST; Wang CI; Dutertre S; Lewis RJ; Adams DJ; Craik DJ; Alewood PF J Med Chem; 2008 Sep; 51(18):5575-84. PubMed ID: 18754612 [TBL] [Abstract][Full Text] [Related]
16. Cyclization of conotoxins to improve their biopharmaceutical properties. Clark RJ; Akcan M; Kaas Q; Daly NL; Craik DJ Toxicon; 2012 Mar; 59(4):446-55. PubMed ID: 21147143 [TBL] [Abstract][Full Text] [Related]
17. alpha-Conotoxins: nicotinic acetylcholine receptor antagonists as pharmacological tools and potential drug leads. Dutton JL; Craik DJ Curr Med Chem; 2001 Mar; 8(4):327-44. PubMed ID: 11172693 [TBL] [Abstract][Full Text] [Related]
18. Delta-conotoxin structure/function through a cladistic analysis. Bulaj G; DeLaCruz R; Azimi-Zonooz A; West P; Watkins M; Yoshikami D; Olivera BM Biochemistry; 2001 Nov; 40(44):13201-8. PubMed ID: 11683628 [TBL] [Abstract][Full Text] [Related]